Annual Report
20
22

Foreword by the Chair

Herwig Leirs

“From the governance perspective the year was marked by four key events: the election of a new alumni representative to the General Council, the selection of five new Governors to the Board, the departure of our long-standing Chair, Cathy Berx and her appointment as Honorary Chair, and the appointment of the new Chair, Jo Bury, who will lead the Board of Governors from 2023 onwards.”
Read the full interview
Portrait image Herwig Leirs

Director's Note

Marc-Alain Widdowson

“Looking back at 2022, I see that after two years of working closely on and during the pandemic, the year brought some needed relief from COVID-19 ushering in one of consolidation and reflection. I’m proud to share examples in this 2022 review, of our continued impact through science for health worldwide. This year has highlighted the importance of institutions such as ITM in a changing world.”
Read the full interview

ITM under the lens

Pathogens, Patients, Populations = P3

Our three scientific departments focus on Pathogens, Patients and Populations (P3) and all contribute to our four core tasks of research, education, medical services and international cooperation.
P3 visualised with an infographic

Research & innovation

Scientific progress in the fields of tropical medicine and international health is at the heart of our institute’s academic mission. ITM’s research activities range from basic to operational research and aim to tackle important health challenges, with a particular focus on low-resource settings and vulnerable populations. Our research policy in 2020–2024 underpins our pursuit of conducting excellent and relevant science, with continued emphasis on equitable partnerships throughout the world. Our research aims to respond to the formidable challenges and opportunities in today’s rapidly changing world: researching (re-)emerging infections and outbreaks, designing sustainable health systems and strategies, accelerating disease elimination, and tackling antimicrobial resistance.

In 2022, many of our researchers focused their attention on another pathogen which rapidly spread from Africa to cause a global epidemic: mpox. Strengthening our work on outbreaks and emerging diseases, a new professor was appointed to lead a new unit on Clinical Emerging Infectious Diseases. In the fall, we opened our Clinical Trial Centre to further strengthen our vaccine research activities.

Research highlights

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Researching (Re-)Emerging Infections and Outbreaks

Mpox: the epidemic of 2022

In spring 2022, an outbreak of mpox (formerly monkeypox) took the world by surprise, causing more than 85,000 infections worldwide, especially among men who have sex with men. Mpox is caused by the mpox virus, of which two types are known. Clade I has been most frequent and has caused several outbreaks in Central Africa, especially in the DRC. Clade II, on the other hand, occurs mainly in West Africa and causes a less severe disease than clade I. The 2022 global outbreak was caused by clade II and was the first time mpox has spread widely outside of Central and West Africa.

Read the full article
Read the full article
Researching (Re-)Emerging Infections and Outbreaks

Journal highlight

Field performance of three Ebola rapid diagnostic tests used during the 2018–20 outbreak in the eastern Democratic Republic of the Congo: a retrospective, multicentre observational study

Authors: Daniel Mukadi-Bamuleka et al.

Read the full article
Read the full article
Sustainable health systems and strategies

Maternal health in a context of rapid urbanisation in Africa

In many African countries, the number of children being born in health facilities is increasing, but without corresponding improvements in the quality of care. The result is that more maternal deaths are attributable to poor quality of care than to the lack of access to care. Analysing data from recent Demographic Health Surveys, ITM researchers and African partners examined how nearly 20,000 women living in 22 large African cities used maternal care services. Cotonou in Benin and Accra in Ghana scored best: here most women were able to access health care facilities and reported receiving timely care. Most cities, however, showed inconsistent levels of accessibility and quality of care across the maternal continuum of care. The proposed typology of best- and worst-performing cities can provide a starting point for extracting lessons learnt and addressing critical gaps in maternal health in rapidly urbanising contexts.

Wong et al. A tale of 22 cities: utilisation patterns and content of maternal care in large African cities, BMJ Global Health, 2022

Wong et al., A tale of 22 cities: utilisation patterns and content of maternal care in large African cities, BMJ Global Health, 2022

Read the full article
Read the full article
Sustainable health systems and strategies

Journal highlight

Doubt at the core: Unspoken vaccine hesitancy among healthcare workers

Authors: Leonardo W Heyerdahl et al.

Read the full article
Read the full article
Disease elimination

Understanding the sexual conversion of the Plasmodium parasite to interrupt malaria transmission

Understanding the sexual conversion of the Plasmodium parasite to interrupt malaria transmission

Malaria is a mosquito-borne infectious disease caused by the Plasmodium parasite that kills more than half a million people every year. Understanding the sexual conversion of the parasite is essential to interrupt transmission. The IMMETASEX research project (host immune and metabolic determinants of sexual conversion in Plasmodium parasites) hypothesises that immune and metabolite factors that are altered during malaria infection induce sexual conversion in Plasmodium falciparum parasites, the deadliest species of Plasmodium.

In this project, the researchers will develop a new tool to estimate sexual conversion rates providing essential knowledge on the factors that affect sexual conversion in the host. This will potentially inform novel strategies to interrupt transmission. Partner institutions of the study include the Barcelona Institute for Global Health and Leiden University Medical Centre. The clinical studies will be conducted in Burkina Faso and in Mozambique. The project is funded by the Research Foundation Flanders.

Read the full article
Read the full article
Disease elimination

Journal highlight

Four layer multi-omics reveals molecular responses to aneuploidy in Leishmania

Authors: Bart Cuypers et al.

Read the full article
Read the full article
Antimicrobial resistance

Evaluating a standardised treatment regimen for patients with multidrug-resistant tuberculosis

Multidrug-resistant TB (MDR-TB) is caused by tuberculosis (TB) bacteria resistant to at least isoniazid and rifampicin, the two most potent TB drugs. In STREAM Stage 2, the first large-scale, multi-country phase III clinical trial of shortened treatment regimens for MDR-TB, a 9-month all oral regimen containing bedaquiline and a 6-month regimen containing injectable and bedaquiline, and both containing a 4th generation fluoroquinolone, were found to be safe and effective. Primary outcome results provide high-quality evidence that support the current WHO recommendation of 9-month, all oral bedaquiline-containing regimens for drug-resistant TB.

Read the full article
Read the full article
Antimicrobial resistance

Journal highlight

Bacteriophage-antibiotic combination therapy against extensively drug-resistant Pseudomonas aeruginosa infection to allow liver transplantation in a toddler

Authors: Brieuc Van Nieuwenhuyse et al.

Read the full article
Read the full article
Researching (Re-)Emerging Infections and Outbreaks

Monitoring vectors and vector-borne diseases in Belgium and Nepal

For more than 10 years, our institute has been actively monitoring exotic mosquitoes in Belgium. ITM and the Belgian public health institute Sciensano have successfully counted on the help of citizens to report tiger mosquitoes via the new website MuggenSurveillance.be. The citizen science project, part of the MEMO+ project, resulted in multiple finds on nine locations. The project was funded by the federal and regional governments through the National Environmental Health Action Plan (NEHAP).

The ITM entomologists did not only find tiger mosquitoes but unexpectedly found the Asian bush mosquito as well. Its presence is an indication of the increasing introduction of exotic mosquitoes in Belgium. In Nepal, ITM studies the interaction between climate change, vector-borne diseases and health through the CLIMB project. As part of the DGD programme, ITM will be working closely together with the BP Koirala Institute of Health Sciences (BPKIHS) and the Nepal Health Research Council (NHRC) to collect information on the spread of vectors and pathogens, pilot new surveillance strategies, and formulate measures.

Read the full article
Read the full article
Researching (Re-)Emerging Infections and Outbreaks

Journal highlight

Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant

Authors: Kevin Ariën et al.

Read the full article
Read the full article
Sustainable health systems and strategies

HIV and migration and 5 years of PrEP in Belgium

The nexus between HIV and migration is gaining attention. Migration to the EU could increase by up to 44% between now and 2030 due to conflict, poverty and climate change. Researchers from ITM’s Sexual and Reproductive Health (SRH) Research Group worked with UNAIDS on a review to assess the level to which HIV affects migrants and what their access to the HIV care continuum is. The findings show that HIV is more prevalent among migrants living in precarious circumstances. They experience multiple barriers in accessing HIV prevention and care: migration and health policies, the health system, the community and on the individual level. To end AIDS by 2030, it is crucial to ensure equitable access to health services, regardless of immigration status, and to implement stigma-reducing interventions.

Nostlinger et al., HIV among migrants in precarious circumstances in the EU and European Economic Area, The Lancet HIV, 2022

Read the full article
Read the full article
Sustainable health systems and strategies

Journal highlight

The impact of COVID-19 on the provision of respectful maternity care: Findings from a global survey of health workers

Authors: Anteneh Asefa et al.

Read the full article
Read the full article
Disease elimination

Improving leprosy prevention strategies

The island of Anjouan in Comoros, an archipelago in the Indian Ocean, has an annual incidence of 7.4 leprosy cases per 10,000 inhabitants – 24 times higher than the global average. As a follow-up to the PEOPLE study, which examined the effect of preventive measures in 110,000 people, ITM, Damien Foundation and Janssen Pharmaceutica started the BE-PEOPLE study in 2022.

In this new study, the combination of bedaquiline with rifampicin is tested as prophylaxis for leprosy among contacts of leprosy patients. Currently, bedaquiline is successfully used to treat multidrug-resistant tuberculosis. Since the bacilli causing leprosy and tuberculosis are closely related, using bedaquiline to prevent leprosy in patients might prove useful. In a safety trial, 310 persons were randomised to either rifampicin or rifampicin plus bedaquiline, and no major toxicity concerns have emerged. In the next phase, we will test the two prophylactic regimens on a population of 120,000 and compare the leprosy incidence.

The study is led by ITM and Damien Foundation and its partner, the National Leprosy and Tuberculosis Control Programme in the Comoros, and funded by Janssen Pharmaceutica, who also generously provide the study compound bedaquiline. Other partners include Leiden University Medical Center and the Netherlands Heart Institute in Amsterdam.

Braet, S. Investigating drug resistance of Mycobacterium leprae in the Comoros: an observational deep-sequencing study. The Lancet Microbe, 2022.

Read the full article
Read the full article
Disease elimination

Journal highlight

Relative contribution of low-density and asymptomatic infections to Plasmodium vivax transmission in the Amazon: pooled analysis of individual participant data from population-based cross-sectional surveys

Authors: Marcelo U Ferreira et al.

Read the full article
Read the full article
Antimicrobial resistance

Tuning diagnosis of bloodstream infections for use in low-resource settings

Bloodstream infections (BSI) are an important concern for public health. In low-resource settings (LRS), they account for more deaths than malaria. Starting appropriate antibiotic treatment early is pivotal for patient outcomes. The current standard for detecting BSI is a multi-day process. Private companies have ameliorated and shortened this process by developing blood culture automates and improved formulas for their blood culture bottles.

However, these are expensive, difficult to maintain and often not available in LRS. In an FWO-funded project, researchers from ITM’s Unit of Tropical Bacteriology examined the composition of commercial blood culture bottles and have evaluated a range of commonly used growth-promoting additives for their effect on bacterial growth. Their findings showed that a very simple blood culture broth supported the growth of the most common pathogens. This information is key to the design of a ready-to-use formulation that can be locally produced and will allow LRS laboratories to implement better and faster diagnosis of BSI.

Read the full article
Read the full article
Antimicrobial resistance

Journal highlight

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

Authors: Christopher J L Murray et al.

Read the full article
Read the full article

Research in numbers

Donut diagram about the research areas at ITM

Research areas of ITM’s publications  with high scientific impact

Antibiotics & Antimicrobials - 10%
Healthcare Policy - 15%
HIV - 5%
Other - 19%
Parasitology - 15%
Tuberculosis & Leprosy - 8%
Virology General - 23%
Virology Tropical Diseases - 5%

Ongoing projects

PhD projects

PhD defenses

Publications

Research in numbers

Infographic of the number of research projects at ITG

Education

More than 500 students and PhD researchers further their education at ITM every year, in expert short courses and postgraduate certificate programmes, advanced master’s courses and doctoral programmes. In January 2022, the first complete cohort of students began our Master of Science in Global One Health: diseases at the human-animal interface. This two-year blended learning course is designed for those who want to work on disease control strategies, ecosystem sustainability, food security and rural development, and is jointly organised with the University of Pretoria.

In 2022, we also started the major restructuring of the Postgraduate Certificate in Tropical Medicine and International Health and the Postgraduate Certificate in Tropical Medicine for Bachelors in Nursing and Midwifery. The new postgraduate certificate programme will start in September 2023 and will focus on the health of vulnerable groups across the globe. The components of the programme can be combined in different ways to fit individual career aspirations.

Finally, in November 2022, ITM’s Education Office participated in a system-wide analysis on education internationalisation in Flemish higher education institutions, organised by the Accreditation Organisation of the Netherlands and Flanders (NVAO).

Global citizenship education for secondary school students

In collaboration with the Flemish broadcaster VRT NWS and other partners, ITM launched two new EDUboxes, educational packages for secondary school pupils, in 2022.

The first one focuses on science for sustainable relationships between humans, animals and the planet. Climate change, urbanisation, globalisation and deforestation are throwing the earth out of balance. Exotic mosquitoes and fungi are also suddenly appearing in our regions. What impact do these phenomena have on the health of humans, animals and the planet?

The second EDUbox introduces students to different health systems around the world; they learn that every person has the right to good health, how governments ensure this, that inequalities persist and how epidemics can put pressure on the entire system.

By means of educational packages that can be used by secondary school teachers, ITM is increasing youth awareness of the institute’s and its partners’ research topics, encouraging them to think critically about the interconnections between global and local challenges.

Four ITM alumni win the Province of Antwerp Prize for Global Research

On 14 September, the annual award ceremony of the Prize for Global Research took place. The prize is awarded yearly by the Province of Antwerp to Master after Master students of the University of Antwerp, the Institute of Development Policy and ITM. Through this award, the provincial government wants to stimulate promising graduation projects on global themes relating to resource-constrained settings.

Four former master’s students of ITM, graduates of the MSc in Public Health, MSc in Tropical Medicine and MSc in Tropical Animal Health, were among the 2022 winners. The prize serves as an important recognition of their hard work and a stimulus to pursue their fields of expertise. The four winning ITM graduates were Claire Julie Akwongo (Uganda), Joseph Bahati Djoki (DRC), Amber Hadermann (Belgium) and Calvin Tonga (Cameroon).

Marjan Pirard awarded Prof Jozef Vandepitte Prize of 2021

In 2021, the Prof Jozef Vandepitte Prize of the association of the Development Aid Doctors & Pharmacists Alumni of KU Leuven was awarded to Dr Marjan Pirard, Education Coordinator of ITM’s Department of Public Health. The prize is awarded every two years to stimulate sustainable educational projects in low-income countries. Dr Pirard received the award for her key role in ITM’s MSc in Public Health (MPH).

Every year, about 40 students enrol in the MPH programme, of which most come from low- and middle-income countries. Since she started heading the Education Unit of the Department of Public Health in 2012, Marjan has supported students and ensured that the programme remains of high quality and relevant in an ever-changing world. "The prize and the heart-warming reactions I received from ITM alumni and staff inspire me in my future work. It is also a recognition of the collective effort of colleagues in our MPH programme,” Marjan said.

Student body

93
postgraduates
74
master’s
158
Belgian students
94
EU-students
257
non-EU students
171
short courses
102
phDs
57
interns
12
master's thesis students

International cooperation

2022 marks the first year of ITM’s new multiannual programme ‘Connecting the Dots – Higher Education and Science for a Healthier World’, supported by the Belgian Directorate-General for Development Cooperation and Humanitarian Aid (DGD). From 2022 to 2026, ITM and its 24 partner institutions in 12 countries will work to increase the quality of, and access to health care worldwide. The focus of the ITM programme is on institutional capacity strengthening and collaboration, with special attention to the training and empowerment of health professionals.

The programme encompasses twelve countries and includes three global programmes. Within our 12 country programmes, ITM and its partners strive for better health for local populations through platform development (knowledge and technology), education and research projects and building synergies. More importantly, we ensure science and education with a high societal relevance by including a component in each intervention to ‘Get Research into Policy and Practice’ (GRIPP).

Through funding from the Flemish Department of Foreign Affairs (FDFA), ITM continues to work on the institutional capacity strengthening of the Instituto Nacional de Saúde, Mozambique (INS) to ensure nation-wide health system strengthening. A new collaboration with provincial health services in Tete province started in 2022 and will focus on decentralised health services and improving the planning capacities and evidence-based decision-making of our partners.

Worldwide impact

Identifying biomarkers for arboviruses to develop new diagnostic tools in Peru
Francesca Falconi is a Peruvian scientist and a 2022 PhD graduate of ITM. Her research focused on arboviruses, which are a common cause of acute febrile illnesses in Latin America, with limited diagnostic options. She aimed to identify specific biomarkers for different arboviruses to develop new diagnostic tools that could detect multiple viruses simultaneously. Falconi conducted fieldwork throughout Peru to collect blood samples and establish a network of collection sites.

Her PhD was made possible by the fourth framework agreement between ITM and DGD. Her current work is a collaboration between ITM and its Peruvian partner, the Instituto de Medicina Tropical Alexander von Humboldt. The project aims to improve disease surveillance in Peru. This includes the development of a highly sensitive real-time PCR machine for arbovirus testing in low-resource settings and metagenomic sequencing to identify any other viruses causing illness.
ITM and Guinean partner train hundreds of Guinean health workers
Following the devastating impact of the Ebola outbreak of 2014, the Guinean government recruited and posted thousands of new health workers in rural areas as part of the health system recovery and resilience plan. Training was needed for these new recruits to reinforce the country’s health system.

ITM and the Maferinyah National Training and Research Center in Rural Health (CNFRSR) developed and provided online courses on primary health care, management of sexual and reproductive health, and research methods to more than 500 Guinean health professionals. This was supported by the Belgian Development Agency (Enabel) and ITM’s fourth framework agreement with the DGD. Building on the success of the past years, the elearning activities have continued under the fifth DGD framework agreement in 2022, with trainings in Primary Health Care and Research Methods. A third course on Sexual and Reproductive Health Services is scheduled for 2023.

Millimouno, Tamba M. Evaluation of Three Blended Learning Courses to Strengthen Health Professionals’ Capacity in Primary Health Care, Management of Sexual and Reproductive Health Services and Research Methods in Guinea. Frontiers in Digital Health, 2022
Building a country-wide AMR surveillance network in Benin
As part of the fifth DGD framework agreement in Benin, ITM’s Unit of Tropical Bacteriology, together with the local partner Laboratoire de Référence des Mycobactéries (LRM), plan to install a country-wide antimicrobial resistance (AMR) surveillance network in Benin. In 2022, the team, consisting of colleagues from ITM and the University Hospital in Cotonou (CNHU), undertook a four-week tour of the seven AMR surveillance network hospitals across the country. After training the local trainers of LRM and CNHU, they trained 100 health workers on the background of AMR, its global and local implications and contributing factors, the need for and diagnostic value of blood cultures, and different procedures for blood culture sampling.

The project’s goal is to have the hospitals from the surveillance network contribute to the WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) and to have them serve as training centres for the containment of AMR in their districts and in francophone West Africa (Benin, Burkina Faso, Guinea). This will ensure best quality laboratory services and patient care for those with severe bacterial infections in the more rural and remote areas.
New countries in the DGD programme: Nepal and Rwanda
Discover all about it in the article below.
Seasonal workers in Ethiopia
Getting research into policy and practice in Ethiopia and beyond
In June 2022, the World Health Organization released its revised guidelines for the treatment of people co-infected with visceral leishmaniasis (VL) and HIV. People living with HIV are 100 to 2,300 times more likely to develop VL, a neglected tropical disease, which is transmitted by the sandfly. If left untreated, it is usually fatal.

The efficacy of the new combined regimen increased to 88% from the 55% of the current standard treatment. The new regimen also has less side effects and the treatment duration is shorter. The new guidelines are based on the results of two studies conducted by the Drugs for Neglected Diseases initiative, Médecins Sans Frontières and their partners in Ethiopia and India.

One of these partners was the University of Gondar, an ITM partner since 2014. The aim of the partnership is to enhance the research capacity and evidence-based medical practice on tropical and poverty-related diseases in Ethiopia, by collaborating on research, training, monitoring, and provisioning state-of-the-art equipment and infrastructure. The new guidelines, which will also be integrated in national guidelines, will enable practitioners to improve their treatment of patients and thus enhance the health of the Ethiopian population.
New countries in the DGD programme: Nepal and Rwanda
Discover all about it in the article below.
Alliance of education and exchange
Institutional capacity building supported by Belgian Development Cooperation
Institutional capacity building supported by Flanders
Seasonal workers in Ethiopia
Getting research into policy and practice in Ethiopia and beyond
In June 2022, the World Health Organization released its revised guidelines for the treatment of people co-infected with visceral leishmaniasis (VL) and HIV. People living with HIV are 100 to 2,300 times more likely to develop VL, a neglected tropical disease, which is transmitted by the sandfly. If left untreated, it is usually fatal.

The efficacy of the new combined regimen increased to 88% from the 55% of the current standard treatment. The new regimen also has less side effects and the treatment duration is shorter. The new guidelines are based on the results of two studies conducted by the Drugs for Neglected Diseases initiative, Médecins Sans Frontières and their partners in Ethiopia and India.

One of these partners was the University of Gondar, an ITM partner since 2014. The aim of the partnership is to enhance the research capacity and evidence-based medical practice on tropical and poverty-related diseases in Ethiopia, by collaborating on research, training, monitoring, and provisioning state-of-the-art equipment and infrastructure. The new guidelines, which will also be integrated in national guidelines, will enable practitioners to improve their treatment of patients and thus enhance the health of the Ethiopian population.
Building a country-wide AMR surveillance network in Benin
As part of the fifth DGD framework agreement in Benin, ITM’s Unit of Tropical Bacteriology, together with the local partner Laboratoire de Référence des Mycobactéries (LRM), plan to install a country-wide antimicrobial resistance (AMR) surveillance network in Benin. In 2022, the team, consisting of colleagues from ITM and the University Hospital in Cotonou (CNHU), undertook a four-week tour of the seven AMR surveillance network hospitals across the country. After training the local trainers of LRM and CNHU, they trained 100 health workers on the background of AMR, its global and local implications and contributing factors, the need for and diagnostic value of blood cultures, and different procedures for blood culture sampling.

The project’s goal is to have the hospitals from the surveillance network contribute to the WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) and to have them serve as training centres for the containment of AMR in their districts and in francophone West Africa (Benin, Burkina Faso, Guinea). This will ensure best quality laboratory services and patient care for those with severe bacterial infections in the more rural and remote areas.
Identifying biomarkers for arboviruses to develop new diagnostic tools in Peru
Francesca Falconi is a Peruvian scientist and a 2022 PhD graduate of ITM. Her research focused on arboviruses, which are a common cause of acute febrile illnesses in Latin America, with limited diagnostic options. She aimed to identify specific biomarkers for different arboviruses to develop new diagnostic tools that could detect multiple viruses simultaneously. Falconi conducted fieldwork throughout Peru to collect blood samples and establish a network of collection sites.

Her PhD was made possible by the fourth framework agreement between ITM and DGD. Her current work is a collaboration between ITM and its Peruvian partner, the Instituto de Medicina Tropical Alexander von Humboldt. The project aims to improve disease surveillance in Peru. This includes the development of a highly sensitive real-time PCR machine for arbovirus testing in low-resource settings and metagenomic sequencing to identify any other viruses causing illness.
ITM and Guinean partner train hundreds of Guinean health workers
Following the devastating impact of the Ebola outbreak of 2014, the Guinean government recruited and posted thousands of new health workers in rural areas as part of the health system recovery and resilience plan. Training was needed for these new recruits to reinforce the country’s health system.

ITM and the Maferinyah National Training and Research Center in Rural Health (CNFRSR) developed and provided online courses on primary health care, management of sexual and reproductive health, and research methods to more than 500 Guinean health professionals. This was supported by the Belgian Development Agency (Enabel) and ITM’s fourth framework agreement with the DGD. Building on the success of the past years, the elearning activities have continued under the fifth DGD framework agreement in 2022, with trainings in Primary Health Care and Research Methods. A third course on Sexual and Reproductive Health Services is scheduled for 2023.

Millimouno, Tamba M. Evaluation of Three Blended Learning Courses to Strengthen Health Professionals’ Capacity in Primary Health Care, Management of Sexual and Reproductive Health Services and Research Methods in Guinea. Frontiers in Digital Health, 2022
Jimma, Ethiopia
Jimma University
Bangalore, India
Institute of Public Health (IPH)
Dharan, Nepal
B.P. Koirala Institute of Health Sciences (BPKIHS)
Kathmandu, Nepal
National Health Research Council (NHRC)
Hanoi, Vietnam
National Institute of Malariology, Parasitology and Entomology (NIMPE)
Phnom Penh, Cambodia
National Institute of Public Health (NIPH)
Yogyakarta, Indonesia
Center for Tropical Medicine, Faculty of Medicine, Gadjah Mada University
Insitutional partners in Latin America
Cochabamba, Bolivia - Post-Graduate Medical School, Universidad Mayor de San Simon (UMSS)
Havana, Cuba - Instituto Nacional de Higiene, Epidemiologia y Microbiologia (INHEM)
Havana, Cuba - Instituto Pedro Kourí (IPK)
Quinto, Ecuador - Institute of Public Health, Pontificia Universidad Católica del Ecuador (PUCE)
Lima, Peru - Instituto de Medicina Tropical “Alexander von Humboldt” (IMTAvH), Universidad Cayetano Herredia
Insitutional partners in Africa
Cotonou, Benin - Laboratoire de Référence des Mycobactéries (LRM)
Cotonou, Benin - Centre de Recherche en Reproduction Humaine et en Démographie’s (CERRHUD)
Ouagadougou, Burkina Faso - Clinical Research Unit of Nanoro (CRUN), including Centre Muraz
Kinshana, DRC - Institut National de Recherche Biomédicale (INRB), Ministère de la Santé Publique
Kinshana, DRC - Programme National de Lutte contre la Trypanosomiase Humaine (PNLTHA)
Lubumbashi, DRC - École de Santé Publique (ESP), Université de Lubumbashi
Kimpese, DRC - Centre de Recherche Sanitaire de Kimpese (CRSK)
Jimma, Ethiopia - Jimma University
Gondar, Ethiopia - College of Medicine and Health Sciences, University of Gondar
Addis Abeba, Ethiopia - Armauer Hansen Research Institute (AHRI)
Addis Abeba, Ethiopia - Ethiopian Institute for Public Health (EPHI)
Conakry, Guinea - Navragen
Maferinyah, Guinea - Centre National de Formation et Recherche de Maferinyah
Rabat, Morocco - École Nationale de Santé Publique (ENSP)
Maputo, Mozambique - Instituto Nacional de Saúde (INS)
Tete, Mozambique - Serviço Provincial de Saúde de Tete (SPS)
Dakar, Senegal - Laboratoires de Virologie, Bactériologie et Parasitologie, Université de Dakar
Cape Town, South Africa - School of Public Health, University of Western Cape (UWC)
Pretoria, South Africa - Department of Veterinary Tropical Diseases (DVRD), University of Pretoria (DVTD)
Kigali, Rwanda - Rwanda Biomedical Centre (RBC)
Kigali, Rwanda - Centre Hospitalier Universitaire de Kigali, University of Rwanda (UR/CHUK)
Kampala, Uganda - School of Public Health (SPH - MUCHS), Makerere University College of Health Sciences
Insitutional partners in Asia
Phnom penh, Cambodia - Sihanouk Hospital Center of HOPE (SHCH)
Phnom penh, Cambodia - National Centre for HIV/Aids, Dermatology and STD’s (NCHADS)
Phnom penh, Cambodia - National Institute of Public Health (NIPH)
Bangalore, India - Institute of Public Health (IPH)
Yogyakarta , Indonesia - Center for Tropical Medicine, Faculty of Medicine, Gadjah Mada University
Dharan, Nepal - B.P. Koirala Institute of Health Sciences (BPKIHS)
Kathmandu, Nepal - National Health Research Council (NHRC)
Hanoi, Vietnam - National Institute of Malariology, Parasitology and Entomology (NIMPE)
Connecting the Dots programme with DGD

New countries in the DGD programme: Nepal and Rwanda

Nepal and Rwanda are two new partner countries within the fifth DGD programme. In Rwanda the capacity strengthening programme focuses on the Rwanda Biomedical Center and the University of Rwanda. The programme aims to strengthen research and services in the fields of tuberculosis, malaria, helminthic infections, proper use of antibiotics, vaccine development and roll-out. In Nepal, the collaborating institutions are the National Health Research Council and BP Koirala Institute of Health Sciences. The partnership aims at improved evidence-based vector-borne disease management, while considering climate impact. Furthermore, the focus is on sustainable elimination of visceral leishmaniasis as a public health problem in the country.
Connecting the Dots programme with DGD

Three global programmes

Our three global programmes focus on Education and Scholarships, Policy Support and Synergies. Through our Education and Scholarship programme, we encourage staff and student mobility and lifelong learning. Our Policy Support directs itself at the Belgian federal government mainly, but also encompasses networks to generate learning and exchange within the global health sector. Lastly, our Synergy programme creates conditions for collaboration between our various country programmes, enables researchers and (partner) institutions to participate in international research projects and offers network opportunities on some of the most pressing issues of our time, including urbanisation, climate change and health.
Connecting the Dots programme with DGD

Joint Strategic Framework

2022 also marked the first year of the new Joint Strategic Framework. ITM joined forces with the umbrella organisations for higher education from Flanders and francophone Belgium, VLIR-UOS and ARES, in a new thematic Joint Strategic Framework on Higher Education and Science for Sustainable Development (HES4SD). The thematic focus enables the framework partners to transcend geographical boundaries and focus on gathering academic expertise, the creation of thematic networks and joint learning on relevant topics for higher education and science (diversity, scholarships, decolonisation, world citizenship education and GRIPP).

International cooperation in numbers

26
institutional partners
19
partner countries

Events

Fundraising

ITM Colloquium

On 6-7 December, our 63rd annual Colloquium took place at ITM, with the theme “Global exchange on COVID-19: takeaways from a pandemic”. The event brought together more than 400 participants from over 30 countries, online and in person. The sessions focused on the heterogeneity of the pandemic in different parts of the world, as some countries suffered from very deadly epidemics, while others contained it well. Participants also zoomed in on the effects of different containment policies, the access and implementation of diagnostics, therapy and vaccines, and the direct and indirect effects of COVID-19 on the health systems and societies.

Fundraising

Opening of Clinical Trial Centre

On 27 September, Johan Hanssens, Secretary-General of EWI, opened ITM’s Clinical Trial Centre (CTC), a brand-new research complex. In the CTC, the institute tests out new vaccines and treatments against infectious diseases before they can be used. Following the opening in 2022, ITM started two trials; one on a new vaccine against COVID-19 (Aesir trial), and another on a shortened administration schedule for administering the rabies vaccine (Single-R trial).

Fundraising

ACL-3 lab: a high-security insectary

In November 2022, ITM opened its firsthigh-security insectary, financed by EWI. An Arthropod Containment Level-3(ACL-3) lab allows researchers to investigate interactions between infectiousdisease agents (Zika, dengue, malaria, sleeping sickness and leishmaniasis) andinsect vectors such as tiger and malaria mosquitoes, tsetse and sand flies.This facility will allow researchers to better understand the relationshipbetween the insects and pathogens and to expand their expertise on the impactof climate change on infectious diseases.

Fundraising

The King and Queen of Belgium pay a visit to ITM partner in DRC

On 9 June, the King and the Queen of the Belgians visited the National Institute for Biomedical Research (INRB), one of ITM’s major partners in the DRC. The visit was organised by the Embassy of Belgium in Kinshasa and the local ITM office. They met with INRB Director Professor Muyembe, and listened to the presentations of scientists working on ITM-funded programmes. These included the microbiological quality of portable hand washing stations and antibiotic resistance, parasitological testing for the diagnosis of sleeping sickness, and the control of emerging epidemics - testimony of a fellow of the Marleen Boelaert Fellowship Programme.

Fundraising

Antwerp Diner: support for HIV research

In October 2022, we received a check for €32,000 from Antwerp Diner! The amount was raised earlier this year during the 20th edition of Antwerp Diner, an annual benefit gala organised to support HIV/AIDS research and prevention. Our researchers will use this donation to better map pre-exposure prophylaxis (PrEP) use and care for PrEP users in our country, in order to advance the long-term understanding and effectiveness of PrEP in Belgium.

Fundraising

Preserving our heritage: restauration of the “Allards”

Nine paintings by the Africanist painter Allard L'Olivier in our main art deco building were restored with the support of the King Baudouin Foundation's Léon Courtin - Marcelle Bouché Fund. The paintings were made for the 1930 Antwerp World Expo. The restoration was in the expert hands of Altri Tempi, who also worked on the paintings in the Antwerp City Hall and courthouse.

Fundraising

ITM launches Marleen Boelaert Study Fund

Via the new Study Fund, we offer promising students from low- and middle-income countries the chance to develop their ambitions in tropical medicine and international public health. The Fund is named after the late Professor Marleen Boelaert, one of the driving forces behind ITM and a global expert on neglected diseases.

Learn how you can support ITM and our activities!

Learn more

Staff
community

Two new heads of department begin

In 2022, Kevin Ariën became Head of the Department of Biomedical Sciences, and Johan van Griensven became the Head of the Department of Clinical Sciences after having been interim head of the department for a year. They shared what has kept them busy during their first year.

Kevin Ariën

“I've been with ITM since 2009, so I've become quite familiar with the Department of Biomedical Sciences and how ITM functions as an organisation. As the new department head, I am eager to set things in motion! In 2022, we have delineated important contours for the future scientific direction of our department with a primary focus on pathogen-vector-host-environment interactions and diagnostics. A vision that was endorsed by ITM’s Scientific Advisory Committee.

For 2023 and beyond, the realisation of new research infrastructure is a major ambition of mine. To remain competitive and relevant in our research domains and to retain and attract highly skilled research talent, it is crucial to have access to state-of-the-art laboratory infrastructure (incl. BSL-3), equipment and technologies. This is of key importance for the whole of ITM. Which ties in with my third ambition, to bring together the expertise of the entire ITM, our three departments, and to make the best possible use of it. Together with Marianne van der Sande from our Department of Public Health and Johan van Griensven from the Department of Clinical Sciences, a more integrated vision both within and between the departments and the rest of ITM will help us achieve even more.”

Johan van Griesven

“At ITM we know the added value of cooperation and how to combine the strengths from the different areas we work on. That is why I aim to connect the clinic, the laboratories and all other parts of the department and ITM even more. This to keep and further strengthen ITM as one of the leading institutes of tropical medicine at the global level. My predecessor, Lut Lynen, has already set a clear direction for our department, but the work is never done. We have to keep evolving in order to remain relevant. Daring to engage in self-reflection is important, detecting and solving bottlenecks. We also have several new professors, units and making these successful is an important mission.

I strive to keep our department an inspiring and motivating environment to work in, one that is ready for the future. That is my main goal. Interdepartmental cooperation is another objective. Keep evolving as a whole, with a good balance between looking ahead and focusing on the current situation.”

Arrivals and departures

2022 marked the appointments of two new professors.
We wish them great success at ITM.

Bernadette Hensen

Bernadette Hensen joined ITM’s Sexual and Reproductive Health Group in the Department of Public Health in September 2022. Her research will focus on sexual health among adolescents and young people, men, and other affected populations, and on the design, implementation, and evaluation of strategies to improve access to sexual and reproductive health services, especially for HIV prevention.

Laurens Liesenborghs

Laurens Liesenborghs became Head of the new Unit of Emerging Infectious Diseases at the Department of Clinical Sciences and a member of ITM’s multidisciplinary Outbreak Research Team. His main research topics include outbreak research, mpox, COVID-19 and viral hemorrhagic fevers, with ongoing projects in Belgium, the DRC, Burundi, Guinea, Ghana and Ethiopia.

Maria Laga

We also send a warm appreciation to our retiring professor – Maria Laga. She started at ITM 38 years ago, at the height of the HIV epidemic, and dedicated her career to the people affected by the disease.

Marie Laga worked as a researcher at ITM and was head of the Unit of Sexual Health including HIV. She is recognised as a leading expert in HIV and advocate of HIV prevention worldwide. She joined ITM in 1984 to work on sexually transmitted infections and HIV, first in Kenya and in the DRC, and later in Côte d’Ivoire. Marie and her team contributed significantly to HIV prevention science in the areas of sexual transmission and its co-factors, prevention programmes for vulnerable groups, evaluation of female-controlled methods and linkages of sexual and reproductive health.

Our staff

Infographic of the ITG staff
49% - 51%
Executive academic, scientific
& medical staff
Infographic of the ITG staff
66% - 34%
Academic, scientific
& medical staff
Infographic of the ITG staff
71% - 29%
Administrative &
technical staff
Our staff comes from 37 countries.

Medical
services

2022 brought a new outbreak that had a major impact on ITM’s medical services: mpox (formerly monkeypox). Given ITM’s ongoing research on mpox in the DRC and its experience with outbreak response, our experts in tropical medicine and sexually transmitted infections confirmed the first mpox patient in Belgium in May and rapidly developed an in-house PCR test. ITM researchers were among the first to publish the sequence of the virus and to demonstrate that an mpox patient does not always present with symptoms and that the virus can be cultured from samples of an mpox patient before the appearance of symptoms. ITM’s laboratory was designated as technical reference centre for mpox in Belgium and our polyclinic was the first in administering vaccinations to patients at risk.

The polyclinic, the side of ITM the Belgian public knows best, is part of our Department of Clinical Sciences. It is ITM’s ambition to provide world-class medical care and laboratory services in the domain of tropical infectious diseases. By conducting clinical and laboratory research, the medical services are nationally and internationally recognised for their expertise and are uniquely placed to advise national and international health authorities and organisations.

Manufacturing in vitro diagnostic tests for neglected tropical diseases

For decades, ITM has been housing a tiny ‘factory’ producing millions of tests every year for the screening and diagnosis of neglected tropical diseases (NTDs): human African trypanosomiasis (HAT) and visceral leishmaniasis, which affect humans, and surra, which occurs in animals like horses and dogs. Early detection is key to combat these diseases. The CATT test (short for Card Agglutination Trypanosomiasis Test), developed by ITM at the end of the 1970s, grew to become one of the most used field tests for detecting HAT or sleeping sickness on a large scale in West and Central Africa. To this day, ITM’s Unit of Applied Technology and Production develops it in-house. Annually, the portfolio now also contains 100,000 DAT/VL tests, used for the diagnosis of visceral leishmaniasis, and 120,000 surra tests, which are sold to veterinary hospitals around the world.

In 2022, the unit concentrated on improving and facilitating some important processes, such as client administration, production planning and stock management. To this end, they put in place a cloud-based ERP (Enterprise Resource Planning)/MRP (Manufacturing Resource Planning) software, suited for small manufacturers. Preparations also began for the setting up of a biobank, with human and non-human biological materials used for research. This will also be accessible to external applicants such as researchers from academic and non-academic origins or from commercial and non-profit organisations.

Guaranteeing high-quality analyses in our 13 reference laboratories

ITM laboratories are highly regarded as scientific centres of reference on tropical diseases, both nationally and internationally. They also work to improve services for patient care locally. In our high-security biosafety level 3+ (BSL-3+) labs we have the infrastructure to safely research dangerous pathogens such as tuberculosis and the Ebola virus.

Several of our research and diagnostic laboratories are recognised as reference laboratories by national governments and various international organisations such as the World Health Organization. As such, ITM’s laboratories are of the highest quality standards and our scientists are often called upon as expert advisors locally and worldwide.

Discover all our reference laboraties

A close-up of our
medical services

40,252
consultations in our
travel and HIV/STI clinics
33,106
administered
vaccinations
507,644
patient sample
analyses

Facts & figures

ITM in numbers

Our financials

Donut diagram of ITG's financials

Profit & loss

Balance sheet

Organisational chart

Our figures